A new test to detect the patients most subjected to coronary arteries' diseases

A new test to detect the patients most subjected to coronary arteries' diseases

(LDL Subfraction)

 

Mabaret Al-Asafra laboratories are the pioneers in the Cholesterol diseases detection leap (Lipoprint):

  • This test helps to measure all cholesterol particles including LDL particles.
  • This test takes about 3 hours.
  • This test helps to detect patients with normal blood cholesterol level but abnormal LDL level.
  • This test helps to determine the extent of patient's response to treatment.
  • This test helps to detect some -difficult to be detected- atherosclerosis diseases.